Italian Multicenter Study on Accuracy of 18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cistaro Angelina, Cassalia Laura, Ferrara Cinzia, Quartuccio Natale, Evangelista Laura, Bianchi Maurizio, Fagioli Franca, Bisi Gianni, Baldari Sergio, Zanella Alessandro, Pillon Marta, Zucchetta Pietro, Burei Marta, Sala Alessandra, Guerra Luca, Guglielmo Priscilla, Burnelli Roberta, Panareo Stefano, Scalorbi Federica, Rambaldi Ilaria, Piccardo Arnoldo, Garaventa Alberto, Familiari Demetrio, Fornito Maria Concetta, Lopci Egesta, Mascarin Maurizio, Altini Corinna, Ferrari Cristina, Perillo Teresa, Santoro Nicola, Borsatti Eugenio, Rubini Giuseppe
Аннотация
PATIENTS AND METHODS: A total of 224 pediatric patients with HL underwent 18F-FDG PET/CT at staging. BMB or follow-up imaging was used as the standard of reference for the evaluation of BMI.
RESULTS: 18F-FDG PET/CT was negative for BMI in 193 cases. Of the 193 patients, the findings for 16 were originally reported as doubtful and later interpreted as negative for BMI, with negative findings on follow-up imaging and BMB. At BMB, 1 of the 16 patients (6.25%) had BMI. Of the 193 patients, 192 (99.48%) had negative BMB findings. Thus, the 18F-FDG PET/CT findings were truly negative for 192 patients and falsely negative for 1 patient for BMI.
CONCLUSION: 18F-FDG PET/CT showed high diagnostic performance in the evaluation of BMI in pediatric HL. Thus, BMB should be ideally reserved for patients presenting with doubtful 18F-FDG PET/CT findings for BMI.